Secondary Prevention of Osteoporosis: If Not Now, When?

Overview

Journal Rambam Maimonides Med J

Specialty General Medicine

Date 2022 Aug 3

PMID 35921486

Authors

Tzvi Dwolatzky

Affiliations

Soon will be listed here.

References

Jeremiah M, Unwin B, Greenawald M, Casiano V . Diagnosis and Management of Osteoporosis. Am Fam Physician. 2015; 92(4):261-8. View

Curran-Groome W, Klein G, Miller S, Hui A, Wilson J, Kuoiloi C . Risk Factors of Recurrent Falls Among Older Adults Admitted to the Trauma Surgery Department. Geriatr Orthop Surg Rehabil. 2020; 11:2151459320943165. PMC: 7385824. DOI: 10.1177/2151459320943165. View

Malle O, Borgstroem F, Fahrleitner-Pammer A, Svedbom A, Dimai S, Dimai H . Mind the gap: Incidence of osteoporosis treatment after an osteoporotic fracture - results of the Austrian branch of the International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS). Bone. 2019; 142:115071. DOI: 10.1016/j.bone.2019.115071. View

Statham L, Abdy S, Aspray T . Can bone turnover markers help to define the suitability and duration of bisphosphonate drug holidays?. Drugs Context. 2020; 9. PMC: 7216784. DOI: 10.7573/dic.2020-1-3. View

Barton D, Smith C, Piple A, Moskal S, Carmouche J . Timing of Bisphosphonate Initiation After Fracture: What Does the Data Really Say?. Geriatr Orthop Surg Rehabil. 2022; 11:2151459320980369. PMC: 8848044. DOI: 10.1177/2151459320980369. View

Shi L, Min N, Wang F, Xue Q . Bisphosphonates for Secondary Prevention of Osteoporotic Fractures: A Bayesian Network Meta-Analysis of Randomized Controlled Trials. Biomed Res Int. 2019; 2019:2594149. PMC: 6885847. DOI: 10.1155/2019/2594149. View

Iida H, Sakai Y, Seki T, Watanabe T, Wakao N, Matsui H . Bisphosphonate treatment is associated with decreased mortality rates in patients after osteoporotic vertebral fracture. Osteoporos Int. 2022; 33(5):1147-1154. DOI: 10.1007/s00198-021-06264-z. View

Bauer D . Osteoporosis Treatment After Hip Fracture: Bad News and Getting Worse. JAMA Netw Open. 2019; 1(3):e180844. DOI: 10.1001/jamanetworkopen.2018.0844. View

Edwards B, Koval K, Bunta A, Genuario K, Hahr A, Andruszyn L . Addressing secondary prevention of osteoporosis in fracture care: follow-up to "own the bone". J Bone Joint Surg Am. 2011; 93(15):e87. DOI: 10.2106/JBJS.I.00540. View

10.

Johnell O, Kanis J, Oden A, Sernbo I, Redlund-Johnell I, Petterson C . Mortality after osteoporotic fractures. Osteoporos Int. 2003; 15(1):38-42. DOI: 10.1007/s00198-003-1490-4. View

11.

Guzon-Illescas O, Perez Fernandez E, Crespi Villarias N, Quiros Donate F, Pena M, Alonso-Blas C . Mortality after osteoporotic hip fracture: incidence, trends, and associated factors. J Orthop Surg Res. 2019; 14(1):203. PMC: 6610901. DOI: 10.1186/s13018-019-1226-6. View

12.

Black D, Geiger E, Eastell R, Vittinghoff E, Li B, Ryan D . Atypical Femur Fracture Risk versus Fragility Fracture Prevention with Bisphosphonates. N Engl J Med. 2020; 383(8):743-753. PMC: 9632334. DOI: 10.1056/NEJMoa1916525. View

13.

Desai R, Mahesri M, Abdia Y, Barberio J, Tong A, Zhang D . Association of Osteoporosis Medication Use After Hip Fracture With Prevention of Subsequent Nonvertebral Fractures: An Instrumental Variable Analysis. JAMA Netw Open. 2019; 1(3):e180826. PMC: 6324295. DOI: 10.1001/jamanetworkopen.2018.0826. View

14.

Reid I, Billington E . Drug therapy for osteoporosis in older adults. Lancet. 2022; 399(10329):1080-1092. DOI: 10.1016/S0140-6736(21)02646-5. View

15.

Aypak C, Bircan M, Ozdemir A . Anti-osteoporotic Drug Utilization Rates for Secondary Prevention Among Patients with Osteoporotic Fractures. Rambam Maimonides Med J. 2022; 13(3). PMC: 9345764. DOI: 10.5041/RMMJ.10473. View

16.

Eastell R, Rosen C, Black D, Cheung A, Murad M, Shoback D . Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society* Clinical Practice Guideline. J Clin Endocrinol Metab. 2019; 104(5):1595-1622. DOI: 10.1210/jc.2019-00221. View

17.

Wu M, Lin Y, Wu C, Lee C, Chen Y, Huang T . Timing of Bisphosphonate (Alendronate) Initiation after Surgery for Fragility Fracture: A Population-Based Cohort Study. J Clin Med. 2021; 10(12). PMC: 8229144. DOI: 10.3390/jcm10122541. View

18.

Petersen M, Jorgensen H, Hansen K, Duus B . Factors affecting postoperative mortality of patients with displaced femoral neck fracture. Injury. 2006; 37(8):705-11. DOI: 10.1016/j.injury.2006.02.046. View